5004.50 -19.50 (-0.39%)

890 NSE+BSE Volume

NSE 09 May, 2025 9:42 AM (IST)



Board Meetings - Procter & Gamble Health Ltd.

The next board meeting for Procter & Gamble Health Ltd. is on 29 May 2025 for the purpose of Audited Results & Final Dividend

Ex-date Purpose Notes
29 May 2025 Audited Results & Final Dividend -
12 Feb 2025 Quarterly Results & Interim Dividend -
04 Nov 2024 Quarterly Results -
21 Aug 2024 Audited Results & Final Dividend -
02 May 2024 Quarterly Results -
06 Feb 2024 Quarterly Results & Interim Dividend -
03 Nov 2023 Quarterly Results -
23 Aug 2023 Audited Results & Final Dividend -
15 May 2023 Quarterly Results -
05 Feb 2023 Quarterly Results & Interim Dividend -
11 Nov 2022 Quarterly Results (Revised)
29 Aug 2022 Audited Results & Final Dividend -
05 May 2022 Quarterly Results & Interim Dividend -
09 Feb 2022 Quarterly Results -
09 Nov 2021 Quarterly Results -
26 Aug 2021 Audited Results & Final Dividend -
06 May 2021 Quarterly Results -
10 Feb 2021 Quarterly Results -
11 Nov 2020 Quarterly Results -
15 Sep 2020 Quarterly Results & Final Dividend -
29 May 2020 Quarterly Results -
07 Feb 2020 Quarterly Results -
07 Nov 2019 Quarterly Results -
08 Aug 2019 Quarterly Results & Interim Dividend -
10 May 2019 Quarterly Results -
27 Feb 2019 Audited Results & Final Dividend -
30 Oct 2018 Quarterly Results -
07 Aug 2018 Quarterly Results -
27 Apr 2018 Quarterly Results -
27 Mar 2018 Others Appointed Mr. Milind Thatte, General Manager Healthcare, as an Additional Director and Managing Director of the Company, in place of Mr. Anand Nambiar, the present MD of the Company.
22 Feb 2018 Audited Results & Dividend -
14 Nov 2017 Quarterly Results -
07 Aug 2017 Quarterly Results -
03 May 2017 Quarterly Results -
27 Feb 2017 Audited Results & Dividend -
11 Nov 2016 Quarterly Results -
25 Jul 2016 Quarterly Results -
12 May 2016 Quarterly Results -
04 Apr 2016 Others To change of Registrar to an Issue and Share Transfer Agent (RTA) from Sharepro Services (India) Private Limited to Karvy Computershare Private Limited.
26 Feb 2016 Audited Results & Dividend -
21 Dec 2015 Shifting of Registered Office & Others Policy on Determining and Disclosure of Material Events/Information as required under Reg. 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 effective December.
30 Oct 2015 Quarterly Results -
12 Aug 2015 Quarterly Results -
07 May 2015 Quarterly Results -
05 Feb 2015 Audited Results & Dividend for the year 31/12/2014
13 Nov 2014 Quarterly Results -
12 Aug 2014 Quarterly Results -
30 Apr 2014 Quarterly Results -
31 Jan 2014 Audited, Quarterly Results & Dividend -
21 Oct 2013 Quarterly Results -
29 Jul 2013 Quarterly Results -
26 Apr 2013 Quarterly Results -
30 Jan 2013 Audited Results & Dividend -
22 Oct 2012 Quarterly Results -
23 Jul 2012 To consider appointment of M.D. inter alia, to consider appointment of Dr. Claus-Dieter Boedecker as M.D. of the Company w.e.f. August 01, 2012 in place of Dr. Marek Dziki whose term of appointment is expiring on July 31, 2012.
20 Apr 2012 Quarterly Results First Quarter
28 Feb 2012 Audited Results (Revised)
01 Nov 2011 Quarterly Results -
26 Jul 2011 Quarterly Results -
25 Apr 2011 Quarterly Results -
08 Feb 2011 Audited & Quarterly Results -
20 Oct 2010 Quarterly Results & Interim Dividend -
28 Jul 2010 Quarterly Results -
23 Apr 2010 Quarterly Results -
29 Mar 2010 Appointment of Additional Director The Board has approved the appointment of Mr. Pramod Pimplikar, VP -Technical Operations of the Company as Additional Director with effect from April 01, 2010.
22 Jan 2010 Audited Results & Dividend -
15 Oct 2009 Quarterly Results -
20 Jul 2009 Quarterly Results -
20 May 2009 Buy Back of Shares To approve a buy-back of its fully paid equity shares of the face value of Rs 10/- up to an amount of Rs 451.1 million being not more than 10% of the total paid up capital and free reserves.
20 Apr 2009 Quarterly Results -
26 Feb 2009 Audited Results & Dividend -
30 Oct 2008 Quarterly Results -
30 Jul 2008 Quarterly Results -
16 Apr 2008 Quarterly Results -
30 Jan 2008 Audited Results & Dividend -
18 Oct 2007 Quarterly Results -
16 Jul 2007 Quarterly Results -
20 Apr 2007 Quarterly Results -
16 Mar 2007 Interim Dividend (Revised)
22 Jan 2007 Accounts & Quarterly Results -
19 Oct 2006 Quarterly Results -
28 Jul 2006 Quarterly & Half Yearly Results -
26 Apr 2006 Quarterly Results -
27 Jan 2006 Accounts & Dividend -
06 Jan 2006 Others Consider inter alia, proposal to sell Companys Life Science and Analytics Division (excluding bulk drugs) to Merck Specialities Pvt. Ltd., a 100% Subsidiary of Merck KGaA, Germany.
29 Oct 2005 Quarterly Results -
29 Jul 2005 Quarterly Results -
13 Apr 2005 Quarterly Results -
18 Jan 2005 Dividend & Accounts -
28 Oct 2004 Quarterly Results -
31 Jul 2004 Quarterly Results -
19 Apr 2004 Quarterly Results -
27 Jan 2004 Dividend & Accounts -
15 Oct 2003 Quarterly Results -
22 Jul 2003 Half Yearly Results -
15 Apr 2003 Quarterly Results -
20 Mar 2003 Dividend Reconsider the rate of dividend recommended for the year 2002 in the Board Meeting 27.01.2003.
27 Jan 2003 Dividend & Others Employees Stock Option Plan
29 Oct 2002 Quarterly Results -
12 Jul 2002 Quarterly Results -